Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
BioNexus Gene Lab Corp
Swot
BioNexus Gene Lab Corp SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
BioNexus Gene Lab Corp has 16 Strengths, 5 Weaknesses, 2 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(16)
Weakness
(5)
Opportunity
(2)
Threats
(0)
Others
(0)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over Half Year (6 Months)
Relative Outperformance versus Industry over the Quarter (3 Months)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Stock gained more than 20% in one month
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
